HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R R Weichselbaum Selected Research

Cyclin D3

9/2000E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R R Weichselbaum Research Topics

Disease

19Neoplasms (Cancer)
01/2017 - 01/2000
4Prostatic Neoplasms (Prostate Cancer)
06/2009 - 01/2001
4Infections
11/2001 - 01/2000
3Head and Neck Neoplasms (Head and Neck Cancer)
03/2013 - 04/2000
2Melanoma (Melanoma, Malignant)
07/2015 - 04/2009
2Glioma (Gliomas)
11/2011 - 10/2001
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2001 - 02/2000
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2016
1Lymphoma (Lymphomas)
05/2015
1Hematologic Neoplasms (Hematological Malignancy)
05/2015
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2003
1Herpes Simplex
09/2002
1Hyperplasia
12/2001
1Carcinogenesis
10/2001
1Adenocarcinoma
10/2001
1Oropharyngeal Neoplasms
03/2001
1Laryngeal Neoplasms (Laryngeal Cancer)
03/2001
1Lewis Lung Carcinoma
09/2000
1Virus Diseases (Viral Diseases)
09/2000
1Breast Neoplasms (Breast Cancer)
08/2000
1Hypocalcemia
08/2000
1Wounds and Injuries (Trauma)
08/2000
1Paresis (Hemiparesis)
08/2000
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2000
1Squamous Cell Carcinoma of Head and Neck
02/2000
1Glioblastoma (Glioblastoma Multiforme)
01/2000

Drug/Important Bio-Agent (IBA)

5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2009 - 06/2001
4Proteins (Proteins, Gene)FDA Link
01/2006 - 01/2000
3DNA (Deoxyribonucleic Acid)IBA
09/2002 - 08/2000
2Cyclin AIBA
11/2001 - 01/2000
1AntigensIBA
01/2017
1Interferon Type IIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
10/2016
1Small Interfering RNA (siRNA)IBA
07/2015
1Alkylating AgentsIBA
05/2015
1Messenger RNA (mRNA)IBA
05/2015
1adenovirus receptorIBA
03/2013
1LuciferasesIBA
11/2011
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
04/2009
1Type I Tumor Necrosis Factor ReceptorsIBA
04/2009
1Prostate-Specific Antigen (Semenogelase)IBA
12/2001
1Phenobarbital (Luminal)FDA Link
12/2001
1Phosphotransferases (Kinase)IBA
11/2001
1ProdrugsIBA
10/2001
1ConnexinsIBA
10/2001
1Connexin 43 (Connexin43)IBA
10/2001
1Pemetrexed (MTA)FDA Link
10/2001
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
09/2001
1Protein Isoforms (Isoforms)IBA
09/2001
1Viral ProteinsIBA
09/2000
1Cyclin D3IBA
09/2000
1EndostatinsIBA
09/2000
1Cisplatin (Platino)FDA LinkGeneric
08/2000
1AngiostatinsIBA
05/2000
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
04/2000
1CeramidesIBA
04/2000
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2000
1Antineoplastic Agents (Antineoplastics)IBA
02/2000
1chelerythrineIBA
02/2000
1Protein Kinase CIBA
02/2000

Therapy/Procedure

9Radiotherapy
01/2017 - 05/2000
8Therapeutics
01/2017 - 01/2000
6Chemoradiotherapy
03/2013 - 04/2000
3Drug Therapy (Chemotherapy)
01/2017 - 03/2008
3Induction Chemotherapy
04/2003 - 03/2001
2Aftercare (After-Treatment)
03/2013 - 02/2000
2Conformal Radiotherapy
01/2002 - 01/2001
2Adjuvant Radiotherapy
03/2001 - 03/2001
1Immunotherapy
01/2017
1Re-Irradiation
03/2013
1Injections
12/2000
1Neck Dissection (Radical Neck Dissection)
08/2000
1Tracheotomy
08/2000